Core Viewpoint - Novartis reported strong Q2 2025 results with double-digit growth in net sales and core operating income, driven by successful product launches and pipeline advancements, alongside a commitment to a significant share buyback program [3][4][5]. Financial Performance - Q2 2025 net sales reached USD 14.1 billion, a 12% increase year-over-year, with constant currency growth of 11% [4][30]. - Operating income for Q2 2025 was USD 4.9 billion, reflecting a 21% increase, while net income rose to USD 4.0 billion, up 24% [4][9]. - Core operating income was USD 5.9 billion, a 20% increase, with a core operating income margin of 42.2% [10][30]. - Free cash flow for Q2 2025 was USD 6.3 billion, a 37% increase compared to the previous year [10][30]. - For H1 2025, net sales totaled USD 27.3 billion, up 12%, and core operating income increased by 21% to USD 11.5 billion [11][13]. Product Performance - Key growth drivers included Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc), and Pluvicto (+30% cc) [5][16]. - The top 20 brands generated USD 11.6 billion in Q2 2025, with a 16% increase year-over-year [17][18]. Strategic Initiatives - Novartis announced an up-to USD 10 billion share buyback program to enhance shareholder returns [3][5]. - The company raised its full-year 2025 guidance for core operating income growth to low teens, while maintaining high single-digit sales growth expectations [5][28]. Research and Development - Significant pipeline milestones included positive Phase III results for Pluvicto in hormone-sensitive prostate cancer and FDA approval for Vanrafia for IgAN [5][19][21]. - Ongoing trials and studies showed promising results for various therapies, including Kisqali and Scemblix, with plans for further regulatory submissions [22][23]. Capital Structure - As of June 30, 2025, net debt increased to USD 23.8 billion, primarily due to cash outflows for dividends and share repurchases [26]. - The company maintains a strong capital structure with a focus on balanced capital allocation [24][25].

Core Insights - CF Industries Holdings, Inc. (CF) shares have increased by 28% over the past three months, outperforming the industry's 18.9% rise and the S&P 500's approximately 15.7% increase during the same period [1][9]. Group 1: Market Dynamics - CF Industries is benefiting from strong global demand for nitrogen fertilizers, driven by robust agricultural activity and recovery in industrial demand post-pandemic [3][4]. - The company projects favorable global supply-demand dynamics for nitrogen in the near term, supported by a low global corn stocks-to-use ratio and weak production economics in Europe [4][5]. - In North America, strong nitrogen demand is anticipated during the spring planting season, with an expected increase in corn acreage by 2025 due to higher returns compared to soybeans [5]. Group 2: Financial Performance - CF Industries generated $586 million in net cash from operating activities in the first quarter, marking a 32% increase year-over-year [6]. - The company repurchased 5.4 million shares for $434 million in the first quarter, with approximately $630 million remaining under the existing $3 billion share buyback program [6]. - A new $2 billion share repurchase program has been approved by the board, set to run through 2029 [6]. Group 3: Revenue Growth - Rising nitrogen prices have led to a nearly 13% year-over-year increase in net sales, reaching $1,663 million in the first quarter [7][10]. - The average selling prices for most core products increased due to higher global energy costs, which raised market-clearing prices to meet global demand [10].

Disclosure of trading in own shares occurred from July 7 to July 11, 2025 Saint-Cloud, July 15, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from July 7 to July 11, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily ...

Group 1 - Aalberts has repurchased 2,500 shares from July 7 to July 11, 2025, for a total of EUR 78,823.16, averaging EUR 31.53 per share [1] - A cumulative total of 2,002,324 shares has been repurchased under the buyback program, amounting to EUR 59,718,534 [2] - The share buyback program is authorized by the AGM held on May 23, 2024, and complies with Market Abuse Regulation 596/2014 and Commission Delegated Regulation 2016/1052 [3]

Group 1 - ASM International N.V. has conducted share repurchases totaling 1,272 shares at an average price of €508.50, amounting to a total repurchased value of €646,807 [1] - The share buyback program, initiated on April 30, 2025, has a total budget of €150 million, with 40.4% of the program completed to date [2] - ASM International specializes in designing and manufacturing equipment and process solutions for semiconductor device production, with operations in the United States, Europe, and Asia [2]

Core Viewpoint - Siili Solutions Plc has conducted a share repurchase, acquiring a total of 900 shares at an average price of 6.60 EUR per share, amounting to a total cost of 5,940 EUR, which increases its total holdings to 29,128 shares [1]. Group 1 - The share repurchase took place on July 14, 2025, on the Helsinki Stock Exchange [1]. - The repurchase is in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052 [1].

Group 1 - JDE Peet's has repurchased 500,106 shares from July 7, 2025, to July 11, 2025, at an average price of EUR 24.28 per share, totaling EUR 12.1 million [1] - The total number of shares repurchased under the buyback program to date is 4,282,329 ordinary shares for a total consideration of EUR 83.4 million [2] - The share buyback program was announced on March 3, 2025, with a total budget of EUR 250 million [1][2] Group 2 - JDE Peet's is the world's leading pure-play coffee company, serving approximately 4,400 cups of coffee per second in over 100 markets [3] - In 2024, JDE Peet's generated total sales of EUR 8.8 billion and employed more than 21,000 employees globally [3] - The company has a portfolio of strong iconic brands including Peet's, L'OR, Jacobs, Douwe Egberts, Kenco, Pilao, OldTown, Super, and Moccona [3]

Group 1: Company Performance - Donaldson Company, Inc. (DCI) is experiencing solid momentum across all segments, particularly in Mobile Solutions and Industrial Solutions, driven by increased demand and market share expansion [1] - The Life Sciences segment is benefiting from rising demand for disk drives and food & beverage products in the Asia Pacific region [1] - DCI's shares have gained 6.3% year-to-date, outperforming the industry which has seen a decline of 2.1% [5] Group 2: Acquisitions and Growth Strategy - DCI has strengthened its product portfolio through strategic acquisitions, including a 49% stake in Medica S.p.A. and Univercells Technologies, enhancing its capabilities in filtration and life sciences [2] - The acquisition of Medica allows DCI to diversify its offerings in medical devices and water purification [2] Group 3: Shareholder Returns - DCI is committed to rewarding shareholders, having paid dividends of $96.9 million and repurchased shares worth $273.8 million in the first nine months of fiscal 2025 [3] - The company has increased its quarterly dividend by 11.1% in May 2025 and has raised dividends for 29 consecutive years [3] Group 4: Financial Challenges - DCI faces challenges from high selling, general, and administrative expenses, with the cost of sales increasing by 3% to $1.76 billion in the first nine months of fiscal 2025 [10] - The overall operating expenses rose by 11.4% year-over-year to $603.7 million, impacting profit margins [11] - Sales in the on-road and off-road segments declined significantly, with on-road sales down 24.6% and off-road sales down 8.3% year-over-year in the third quarter of fiscal 2025 [9]

Core Insights - Applied Industrial Technologies, Inc. (AIT) is experiencing growth in its technology, food & beverage, pulp & paper, and transportation markets, with the Engineered Solutions segment's revenues increasing by 13.5% year over year in Q3 of fiscal 2025 [1] Group 1: Market Performance - The Engineered Solutions segment is benefiting from strong demand in technology-related fluid power, automation, and industrial verticals, contributing to revenue growth [1] - AIT's stock has gained 31.5% over the past year, outperforming the industry growth of 9.7% [8] Group 2: Acquisitions and Growth - The company made strategic acquisitions, including IRIS Factory Automation, which is expected to enhance its automation offerings and contribute positively to sales [2] - The acquisition of Hydradyne is anticipated to boost fluid power offerings and create cross-selling opportunities, adding $260 million in sales and $30 million in EBITDA [3] Group 3: Financial Returns to Shareholders - AIT has been committed to returning value to shareholders, paying out $46.2 million in dividends in the first nine months of fiscal 2025, marking an 11.2% increase year over year [4] - The company increased its quarterly dividend rate by 24% in January 2025 and authorized a new share buyback program to repurchase up to 1.5 million shares [5] Group 4: Challenges - Despite the growth in certain segments, AIT is facing challenges in its Service Center Based Distribution segment due to reduced spending on maintenance and operations, which has negatively impacted performance [9] - The company's SG&A expenses increased by 4.1% year over year, with a rise in operating costs affecting overall profitability [10]

Core Viewpoint - Genius Group Limited has initiated a share buyback program, purchasing one million shares at an average price of $1.30 per share, following shareholder approval for a buyback of up to 20% of its issued ordinary shares [1][4]. Group 1: Share Buyback Details - At the Annual General Meeting on July 7, 2025, shareholders voted 98.8% in favor of the share buyback mandate, allowing the Board to repurchase up to 20% of the Company's issued ordinary shares within the next twelve months [2]. - The Board authorized the CEO to execute the buyback, allowing for the repurchase of up to 100% of the approved limit of 20% of Class A Ordinary Shares [3]. - The one million shares repurchased represent 7% of the total shares permitted for buyback under the approved mandate, and these shares have been returned to the Company's treasury [4]. Group 2: Compliance and Future Actions - The Company and its broker adhered to guidelines under Rule 10b-18 and Rule 10b-5 of the Securities Exchange Act to ensure compliance during the share repurchase [5]. - The Company may conduct further buybacks within the approved mandate based on market conditions and the Company's share price relative to its enterprise and net asset value [6]. Group 3: Company Overview - Genius Group is a Bitcoin-first education group that provides AI-powered education and acceleration solutions, serving 5.8 million users across over 100 countries [7].